Orthofix Medical Inc. (OFIX)
NASDAQ: OFIX · Real-Time Price · USD
10.42
-1.78 (-14.59%)
At close: Aug 5, 2026, 4:00 PM EDT
10.54
+0.12 (1.15%)
Pre-market: Aug 6, 2026, 7:59 AM EDT
Orthofix Medical Revenue
Orthofix Medical had revenue of $210.93M in the quarter ending June 30, 2026, with 3.85% growth. This brings the company's revenue in the last twelve months to $833.19M, up 2.99% year-over-year. In the year 2025, Orthofix Medical had annual revenue of $822.31M with 2.85% growth.
Revenue (ttm)
$833.19M
Revenue Growth
+2.99%
P/S Ratio
0.51
Revenue / Employee
$519,119
Employees
1,605
Market Cap
424.43M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 822.31M | 22.82M | 2.85% |
| Dec 31, 2024 | 799.49M | 52.85M | 7.08% |
| Dec 31, 2023 | 746.64M | 285.93M | 62.06% |
| Dec 31, 2022 | 460.71M | -3.77M | -0.81% |
| Dec 31, 2021 | 464.48M | 57.92M | 14.25% |
| Dec 31, 2020 | 406.56M | -53.39M | -11.61% |
| Dec 31, 2019 | 459.96M | 6.91M | 1.53% |
| Dec 31, 2018 | 453.04M | 19.22M | 4.43% |
| Dec 31, 2017 | 433.82M | 24.04M | 5.87% |
| Dec 31, 2016 | 409.79M | 13.30M | 3.35% |
| Dec 31, 2015 | 396.49M | -5.79M | -1.44% |
| Dec 31, 2014 | 402.28M | 4.67M | 1.17% |
| Dec 31, 2013 | 397.61M | -42.58M | -9.67% |
| Dec 31, 2012 | 440.19M | 4.67M | 1.07% |
| Dec 31, 2011 | 435.52M | -27.05M | -5.85% |
| Dec 31, 2010 | 462.57M | -83.06M | -15.22% |
| Dec 31, 2009 | 545.64M | 25.96M | 5.00% |
| Dec 31, 2008 | 519.68M | 29.35M | 5.99% |
| Dec 31, 2007 | 490.32M | 124.96M | 34.20% |
| Dec 31, 2006 | 365.36M | 52.06M | 16.61% |
| Dec 31, 2005 | 313.30M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Varex Imaging | 857.50M |
| Viemed Healthcare | 301.61M |
| OrthoPediatrics | 252.72M |
| Cerus | 221.55M |
| Cytek Biosciences | 204.17M |
| Pacific Biosciences of California | 160.03M |
| NeuroPace | 99.53M |
| Delcath Systems | 90.44M |
OFIX News
- 17 hours ago - Orthofix price target lowered to $13 from $15 at Stifel - TheFly
- 1 day ago - Orthofix Medical Earnings Call Transcript: Q2 2026 - Transcripts
- 1 day ago - Orthofix Medical Slides: Q2 2026 - Filings
- 1 day ago - Orthofix Medical Earnings release: Q2 2026 - Filings
- 1 day ago - Orthofix Medical Quarterly report: Q2 2026 - Filings
- 1 day ago - Orthofix Reports Second Quarter 2026 Results Reflecting Continued Operational Progress - Business Wire
- 7 days ago - Did Orthofix Medical Inc. Insiders Breach their Fiduciary Duties to Shareholders? - PRNewsWire
- 15 days ago - MedTech Pioneer Max Reinhardt Joins eXeX to Drive Canopus Platform Growth - PRNewsWire